AMARIN CORP PLC\UK Treasury Stock, Value
AMARIN CORP PLC\UK (AMRN) had Treasury Stock, Value of $69.29 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2026-07-29
- 2026-06-30: Treasury Stock, Value $69.29M.
- 2026-03-31: Treasury Stock, Value $69.05M.
- 2025-12-31: Treasury Stock, Value $67.36M.
- 2025-09-30: Treasury Stock, Value $67.36M.
| Period end | Treasury Stock, Value |
|---|---|
| 2026-06-30 | $69.29M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $69.05M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $67.36M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $67.36M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $67.11M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $66.44M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $65.33M 10-K · filed 2026-03-02 |
| 2024-09-30 | $65.34M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $65.28M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $65.19M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $63.75M 10-K · filed 2025-03-12 |
| 2023-09-30 | $63.74M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $63.46M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $63.28M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $61.77M 10-K · filed 2024-02-29 |
| 2022-09-30 | $61.59M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $61.42M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $61.26M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $60.73M 10-K · filed 2023-03-01 |
| 2021-09-30 | $59.60M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $59.01M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $58.33M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $51.08M 10-K · filed 2022-03-01 |
| 2020-09-30 | $50.73M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $50.25M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $49.73M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $35.90M 10-K · filed 2021-02-25 |
| 2019-09-30 | $20.53M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $20.53M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $19.49M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $10.41M 10-K · filed 2020-02-25 |
| 2018-09-30 | $9.87M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $6.91M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $6.78M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $4.23M 10-K · filed 2019-02-27 |
| 2017-09-30 | $4.05M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $3.90M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $3.73M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $1.50M 10-K · filed 2018-02-27 |
| 2016-09-30 | $1.35M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $1.20M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $1.10M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $411.00K 10-K · filed 2017-03-01 |
| 2015-09-30 | $368.00K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $334.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $334.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $217.00K 10-K · filed 2016-02-25 |
| 2014-09-30 | $217.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $217.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $217.00K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $217.00K 10-K · filed 2015-03-03 |
| 2013-09-30 | $217.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $217.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $217.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $217.00K 10-K · filed 2014-02-27 |
| 2012-09-30 | $217.00K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $217.00K 10-Q · filed 2012-08-08 |
| 2012-03-31 | $217.00K 10-Q · filed 2012-05-08 |
| 2011-12-31 | $217.00K 10-K · filed 2013-02-28 |
| 2011-09-30 | $217.00K 10-Q · filed 2011-11-08 |
| 2011-06-30 | $217.00K 10-Q · filed 2011-08-09 |
| 2010-12-31 | $217.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |